HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Eyes Targeted Innovation, China Opportunities Amid Transformation

This article was originally published in The Rose Sheet

Executive Summary

CFO Jon Moeller drives home that P&G is "operating in a more volatile environment than we ever have" as it continues shedding slow-growth brands. Hair care and grooming are high among the streamlined company's strategic priorities, as well as the US market and China.

You may also be interested in...



P&G Endures 'Top-Line Pain' As Portfolio Streamlining Prioritizes Premium Products

The firm reports slumps between 1% and 5% across each of its product categories, but also encourages analysts with reports of sometimes significant progress in its "transformation" initiatives in productivity, portfolio, organization and top-line growth.

P&G Endures 'Top-Line Pain' As Portfolio Streamlining Prioritizes Premium Products

The firm reports slumps between 1% and 5% across each of its product categories, but also encourages analysts with reports of sometimes significant progress in its "transformation" initiatives in productivity, portfolio, organization and top-line growth.

P&G Beauty Dragging With Olay Quiet, Coty Brand Takeover Ongoing

Olay sales slipped on an organic basis during the firm's third quarter, despite efforts over the past year to kickstart the brand, and strong Pantene and Head & Shoulders performances in hair care couldn't offset underperformers. Efforts to close the firm's $12.5bn merger deal with Coty likely continue to weigh on the P&G's beauty performance, with sales down 8% to $2.7bn for the period.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS020000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel